You are on page 1of 56

(.....

22 2011 - - 2012

4052 (1 2012)
...
.....


5
6
18
19
20
24
28
36

ditorial
-
4052 (1 2012)

...

.....
(...)

38
38
39
40
40


....
...
...


42

45
46

.....
, 15 2011
.....

49
50


21 .
. & ()
Janssen-Cilag Caelyx

54


1 :

48
48

(.....)

22 2011 - 2012

.....

: / . .
: / ... -
. : / ..
: / ..
: / ,
/ .. ,
/ ..

.....

99,
115 27
./fax: 210 7753104
e-mail: pefni@ ath.forthnet.gr
http://www.pefni.gr



, , ,
, , ,
, , ,
, , ,

.....

editorial

...
,
.
.
..... ,
, . . ...!

.

, .
2012 :
)  :
, .....,

.
) 
.., :
20-22 .

)  1
27-30 .

, ,
,
: ( , )
(
) - (

).
,
....
.
,
.

, ,
....., , .
.

-
4052 (1 2012)
4052
: 4:
6: 12: , 13: 15 14:
21: 23 25.
. 4052:



(....),
,
,

.



[...]
4


1.
 ,

, ,


.
2.  . 4 34
. 2519/1997 ( 165) :
.
.

. 1397/1983.

3.  . 5 7
. 2889/2001 ( 37) :
.
250 .
4.  . 2 8 . 2889/2001 ( 37) .
5.  ,
,
(1) . ,
,
(1) .
6.  . 6 6 .
2889/2001 ( 37) : 200 , :
)

) - .
7.
 30 . 3209/2003 (
304) .
8.  2 3 . 2
17 .. 95/2000 ( 76)
:
2)  ,
,

, ,
.

-
3) 
,
, .
9.
 18 2 15
.. 95/2010
( 76) 19 :
19) .
10.  8 2 16
.. 95/2010
(76) .
[...]
6

1.  . 2 17 . 1397/1983 ( 143) : 2.

, ...
.
.

,
...,

,

.

,

,
.
.
,
. . 1
,

,
.
2.
 . 5 18 . 1397/1983 ( 143) : 5. ,
...
.
. ,
...,


,
.

,



,
.
. ,
.
3.  . 3918/
2011 (31) ,
,

.....
.
4.  5 . 3868/2010
4 : 4.

.
.

-
(6)
.

, .
5.  . 2 10 . 3329/2005 (81) : 2.
...
, ,
, ,
, , ,
, ,
, , , , ,
, ..., ,
, , ,
, , , -,
, ,
, , ,
,
, /,
,
, .
, .

40% 60%.

.
,
, .... ,


.


..

6.  (1)

. . 2 21 . 3580/2007 (
134) :

(1)
.
,

.
7.  . 5 6 . 2889/2001 (37) : (...) ...
.
8.
 5 . 3868/2010 4
: 4.

31.12.2011,

, (6)

.
31.12.2011
, , (6)

. ,
,

,

...,
(6) .
9.  . 4 45 . 3205/2003
( 297) 01.01.2012 0,0052.
. 4
- 01.01.2012
(49%).

-
10.  ... 2011
,

2012.
, .
11.  . 5 22 . 4025/2011 ( 228) : 5.
, ,
.
12.
 ,
...
, ,
...
,

...
.
13.  ...,

,

,
. ,
, , , ,
, , ,
, , ( ),
.
14.
 2
155 .... ( ) :
..., 65 .
[...]


.....
[...]
12
,

1.  ()
. 3
12 . 3816/2010 ( 6),
1 3 36 . 4025/ 2011
( 228),
.

. ,


, .
2.  (rebate)
.1 35 . 3918/2011
, 11
,
36 . 4025/2011,
.
3. 
-
.
13
.....

[...]
15.  72 . 3918/2011 : 1.

. 3457/2006

,
.

-
/ ..... 2.

. 3892/2010 : )
(150) ,
) - 1 . 3459/2006
) (3)
..... 3. ,

,

.. .....



14
1.  2 . 4 8 . 3918/2011
(31) .
2.
 . 1 15 . 3918/2011 (31) : 1.
1,2,3,4,5,6,11 12 . 3918/2011 01.01.2013.
8, 9 10
, 2013.
3.
 . 1 16 . 3918/2011 (31) : 1. ,
2013 ...,
15 . 3918/2011, ,
,
, 30.6.2013.
4.
 . 2
5 . 3886/2010 (173) :

,
... 3580/2007, 3846/2010,
3867/2010, 3868/2010 3918/2010 ...,
.

10

5. 
,


-
.
6. 

.... 2010-2012 30.06.2013 .. (
.... ) 4/.84624 (1681) ( ....
...),
.

() .... 2013

...
.... 2010 . 10 27
. 3867/2010 .
7.  . 1 13
.3918/2011 (31) :
(....) 2011

,

,
24 . 3846/2010.
8.  . 3 1 . 3580/2007
( 134) :
.
9.  3 44 . 4025/2011 (228) .
[...]

-


21
1.
 5 17
.. 96/1973 (172), ,
: ) ,
,
(50%).
() ,
(60%)
, .



. ... .
2. 

,
10%
.
,
,
, , ,
.
3.  ,
,

,
.

, -

...,
4,9%
.
4. 


( ).

...,
.

...
.
,
.
5.
 ) ... 1 2012 ( ).

. ) 1
2012 ... ( )
(10) ,

11

-
, .
,
10
,
. 1 2012
. )


,
31 2012.
6.  , 1
38 . 4025/2011 (228),

.
,


.

, ...
.
7.
 1 12
. 3816/2010 ( 6), ,
:
. ,
, (Anatomic Therapeutic
Chemical classification - ATC)
(...) (..)
.
(...)
.
, , , .

,
...
-

12


,
, .


01.01.2012,
2/3 - 12 - ,

,

89/105-/ . ,
,
.
,
,
. 3/.
104893 ( 2141 /26.9.2011)
37 . 4025/2011 ( 228)

. 3/..95872 ( 2155).
[...]
23
1.  . 2 12 . 3816/2010
(6) : .
,
, , ...,
2 : i)
ii)
.

.
.
) +5%+...,
)
-

-



.
2. 40 . 3918/2011 ( 31) : ,
,
,

, ...
.

200, :


+5% +.
[...]
25

. 2 12 . 3816/2010:

* 500

+2% +8% +30

501-1000

+2% +7% +30

1001

+2% +6% +30

* = +2%.

. 2, 12
. 3816/2010, 200 :

200-500

+8% +30

501-1000

+7% +30

1001

+6% +30

, 15 2012,
200
, 30 .
3. 9 . 2889/2001 ( 37) 10, :
10. 2
12 . 3816/2010 ( 6) -

...

.

5%
7
9 . 2889/2001.

,

,
,
.

.

,
.

.
.

13

-


2008/104// 19.11.2008

19 2008


[]


[...]
134

1.  ...

. ...
- ... , 80
,
.
, .
. .
,
, , ,
,

. ,
,

, .
,

.
,
,
.

14

2.
 ... ,
, ,
.
, 9 . 2889/2001.
: 1) , 2)
,
, 3) ,
.
,
.
3.  , ,
,
, ,
.

, , . ,

.
,

. : 1)

. 2)
. 3)
. 4)
, .
5) ,

-
-- , .

,
.
4.  ,
, ,
,
, .
5. 
,
.
6.  ,

.
135

-
1. .  ...
,
-
/,
... ,
.
,
, -,
, ,

.
... .

. 

, .
,

,

, , ,
, , , , .

.
. 

,
.
. 
,

. ,
.
.

.

, .
.
 ,
, .



.
,
.

15

-
. 
, , , .
.  , .
2. .
 1 ,
, ,

, , .

,

,
,
,

, .
.  ,

.
. 
, , .
.
 .

-, -,
-, .

, ,
. ,
. -

16


, , ,
. .

, .

. ,
,

.
. 
,

.

. ,
,
,




.
, 1
.
.

.

, , .
.

, .
.
.

-
4052/2012 .....

1.
 134 . 3, . 1172 :
, ,
,


[...]
:
.
2. 134 . 4, . 1172 :

, ,
, -

,
[...]
3.
 134 . 5, . 1172 :

.
4.
 135 . 2, . 1173 :


.
. 1173 :
.
,
.. .....

MSc


MSc

NOMA : IREMOFAR. ( ): 25mg/tab: 25mg Hydroxyzine hydrochloride. 10mg/5ml: 5ml


10mg Hydroxyzine hydrochloride. : . . : : .
. . : . : : 50mg
12,5-12,5-25mg. 300mg . : 25mg .
25mg, 3-4 . : 50-200mg 1 2 : 1 .
. 200mg, 300mg. ( 12 ): : 12 6 : 1mg/kg .. ,
2,5mg/kg .. , . 6 : 1mg/kg .. , 2mg/kg .. , . :
1mg/kg .. . 1mg/kg .. . : ,
. , . 33%.
, . : , , , .
. , ( . 4.6). 25mg/tab: IREMOFAR . , Lapp
. 10mg/5ml: IREMOFAR 10mg/5ml 5mg ml. ,
. : , .
( 4.8). . , , ,
, . ( 4.5). (
4.5). , . ,
. ( 4.2). 6,5ml IREMOFAR 2mg/ml,
. . IREMOFAR 2mg/ml (1,0mg) (). 100ml ( 200mg
) 100mg, 2,5ml 1ml . , ,
. 5 , .
: . .
, . : ,
. : : . : , . : ,
, , . : , , . : , . : .
: , , , , , , , . : , , , . : .
, : . : , , , , - , , , .
: . : UNI-PHARMA ....: 14 . 1, 145 64 , .:210 8072512, Fax: 210 8078907. : 8570/06.02.2007.
: 26.11.2009. Iremofar C. tab. N.T. 1.16, .. 1,91 Iremofar Oral sol. N.T. 1.04, .. 1,73 ( ). : .

17

spc

: .. . .
: . 4052/2012

, 15.03.2012
. .: 385

-

.... . .: 3()/. 141292
21.12.2012.

, 21.12.2011
. .: 3() /.141292

& /
/ /
17, 101 87
: 210 5237483, Fax: 210 5227360
:
:
 90
, .. 63/2005 ( 98/)
 .. 96/73 ., 784/78,
1316/83, 1965/91, 1969/91, 2992/02, 3408/05, . 3790/09
. 3840/2010
 45 . 12 . 2992/2002 ( 54//20.03.2002)
 . 3842/2010 ( 58//23.04.2010)
 69 . 3984/2011 ( 150//27.06.2011)
 4 . 2 36 . 3899/2010 ( 212/
/17.12.2010) ...
 .. 136/46 ,
 .. 109 110/11.11.2011 ( 243/./11.11.2011)

, ,

 .. 07/2009 ( 1388//09)
14.05.2009,
 .. 95/2000 ( 76//2000)
 40 51 . 3918/2011 ( 31//31.03.2011)

18

 39 . 3918/2011 ( 31//02.03.2011)

 38 . 3918/2011 ( 31//02.03.2011)

 32 . 1316/1983
, .
 . 1/.35997/
11.4.2011
 . . 3/..52241/11.05.2011 (
840//02.05.2011)
 . . 3/.85781/27.07.2011 (
1666//27.07.2011) . 12 . 2 . 3816/2010
 . . 3/.128948/22.11.2011 ( 2785//
02.12.2011)
 19.12.2011


.

1


,
, :
2


.

... 6,5%.
 ...

1,41%.

-
3
&
23.12.2011.
16 2012.

, .. 136/46
.
Y &

...
.. .... .

7 .. : ...

,

,

...,

30
.
.
....
.

1 .. 1 ..

: ...

,

,
. .
10/../103252/19.09.2011 ... , (9)
(10)

1 .. ,

, .

&
3 (...)

(12) :
(1) .. .
 .. (12) :
(1) .. .
 .. (12) :
(1)

(1) .. .

 ..
(12) :
(1) .
 .. (12) :
(1) .. .

19

2011
, 30.12.2011
..: 10/../121782






: 17
: 101 87
: ., .
.: 2105247421
:
, ,
, , ,
, ,
,
:
1.  . 10/..155687/24.1.2011 ( 51/25.1.2011)
, ,
, , , , , , , . 10/.. .97818/01.09.2011 (
2259/11.10.2011/) 10/139675/30.12.2011 (
3191/30.12.2011/)
2.  . 10 /..14913/28.02.2011 ,
. 10/114217/24.10.2011
3. 
.
:
. 10/.. 14913/28.02.2011
, , , , , , , , ,
. 10/114217/24.10.2011
(1.500.000,00)
:

20

...

60.000

... .

40.000

1.000

2.100

...

25.000

...

23.000

...

32.500

...

30.500

...

55.000

... .

20.000

...

20.400

35.000

..

8.800

...

2.000

...

6.600

8.000

..

14.800

14.800

..

5.600

..

5.600

.. .

11.000

...

25.700

11.250

.. .

8.300

.... -

27.500

..
..

5.800
10.100

..

5.400

....

1.100

....

1.100

.... .

8.300

40.000

.. - ..

. .

18.800

...

1.100
20.000

3.300

..

2.600

..

2.500

..

3.500

.. - ..

9.000

..

15.100

.. &

..
..
.. .

12.000

..

5.000

..

5.400

...

77.000
10.000

..

19.500

..

.. .

45.000

..

.. - ..
..

2.400
3.300

4.000

1.100

..

4.100

..

20.000
7.500

...

25.000

..

7.900

..

21.700

..

6.400

10.000

..

2.400

.. . /

4.500

..

1.400

.. /

4.000

..

1.300

31.700

..

1.150

. /

3.600

.. - ..

1.250

..

1.000

.. - ..

2.700

..

3.100

...

33.000

..

2.800

..

25.000

..

4.500

....

54.000

..

3.800

....

2.300

..

4.300

..

2.500

.. - ..

1.100

..

6.800

..

8.250

..

10.000

.. .

..

2.500

..

2.800

..

1.400

..

2.600

..

1.400

.. /

23.250

... /

25.000

.. / .

2.400

..
.. - ..

1.100
0

.. - ..

2.100

..

8.300

..

1.250

..

1.100

. /

16.000

.
/

2.400

..

5.100

..

..

7.500

..

3.000

..

5.250

..

7.400

..

4.500
30.000

21

...

4.500

..

23.000

...

34.750

..

8.100

..

18.750

..

4.900

..

3.700

.. - ..

1.200

.. - ..

2.300

.. - ..

1.200

..

5.800

.. - ..

1.200

..

1.100

...

..

1.700

..

3.250

..

1.200

..

3.600

..

10.000

...

40.000

...

20.000

7.500
1.500.000

. 10/.. 14613/
28.02.2011 , .
Y &

. 4038:

2012-2015.

2011 4038
32 6 ( 14/02.02.2012).
[...]



[...]
32

[...]

22

6.
 . 1 20 . 4024/2011 (226),
8 9 :
9. (......)
(....)
,
,

, .

-
.....
12, . 2

. 3816/2010

, 20.12.2011
. .: 3()/.. 140492
, , 12, . 2 .
3816/2010, (...), :

25675

...

...

01.07.2011

1

6

* .

, 1
.
, 1
.
,
,
8, . 4 . 3457/2006.


,
,
.
.

:
)  ( )
)  .
,

24

,
.

,

.

.

. ..

. . .. :
..... :
12, . 3816/2010 .....,
.

..... .. .
.... .
.....
, 18.01.2012
. .: 373
: .. .... .
: .....

. . 1043/13.01.2012

:
1.
 -

,
;
2.

12 .
3816/2010
,
2012;
,
.. .....

MSc


MSc

. 3459/2006


, 13.12.2011
..: 3/121296

& .
/ / / & /
. : 17, 101 87

: .
: 210 5225301
:
. 3459/2006 .
:
1.  . 3459/06
(...), 1, 2, 5, 7 22 ( 103/
./2006)

25

-
2.  . 6/6543/15.07.1988
4 . 1729/87... ( 535/
./1988)
3.  .. 95/2000 ( 76/./2000)

4.  49 . 3370/2005 ( 176/
./2005) 51, .
2 3 . 3918/2011 ( 31/./2011)

5.  . 59172/26.08.2011, 59173/26.08.2011,
59174/01.09.2011, 59175/01.09.2011
...
Fentanyl
Lavipharm 25mg/h, 50mg/h,
75mg/h 100mg/h

6.  03.11.2011 Lavipharm S.A.


7.  ,
. 5/15.11.2011
8. 
.
:

Fentanyl Lavipharm 25g/h, 50g/h, 75g/h 100g/h
(Transdermal Patches Fentanyl) . 3459/2006 .
.
Y &

.....
. 71 11/21.11.2011
01.11.2011
, ,
..... .

, 12 2012
. .: 213
: .....
:
1. .. ..... . 71 11/21.12.2011
2. .. ..... . 70 11/21.12.2011
.....,
:

26

. 70 11/21.12.2011

, .....
.
,


,
.
.....
.

-
(...)

. ... 3/2011
, 08.12.2011
. . 10565


. 81/18.11.2011
[...]
:

,
:
1)  , .....
, ,
.
2)  ,
, , .
3)  ,
,
, ...
-.

4)  , ,
,
.
5)  ,
, ,
.
, , , .
,
, .
13.12.2011,
9.30.. ( 3, , 1 , . : 213 2010402).
.

...

... 4/2011
, 19.01.2012
. .: 451
:


&

28


. : 3
..: 11521-
URL: www.epromy.gr
: . , .
: 2132010579/557
. . .: 2132010433

-
E-mail: nkapetaneas@yyka.gov.gr
magda.kanari@epromy.gr

:


. ... 4/2011
. ... 4/2011
www.epromy.gr,
12 .
3 .

GRANULOKINE INJ. SOL. 5 PF. SYR. x


30MU (300MCG)/0,5ML
GRANULOKINE INJ. SOL. 5 PF. SYR. x
48MU(480MCG)/0,5ML
NIVESTIM, INJ. SO. INF. 30MU
(300MCG/0,5ML), 5 PF. SYR. x 0,5ML
NIVESTIM, INJ. SO. INF. 48MU
(480MCG/0,5ML), 5 PF.SYR. x 0,5ML
ZARZIO SO. INJ. INF. 30MU (60MU/
ML) 0,5 ML PF SYR BT x 5 PF.SYR.
ZARZIO SO. INJ. INF. 48MU (96MU/
ML) 0,5 ML PF SYR BT x 5 PF.SYR.

1.904

337.008,00

3.232

859.712,00

481

85.137,00

1.750

465.500,00

861

152.397,00

1.708

454.328,00
2.354.082,00

, 26.01.2012
. .: 613

,
,

,


. ... 2/2011 .

:

. ... 4/2011
. ... 4/2011

www.epromy.gr . . 451/19.01.2012

...

... 4/2011

... . ... 4/2011.


...
: . ... 4/2011

,
. ... 4/2011.

,
.

.
.



, ,

29

-
...


, 03.02.2012
..: 889

:

2012

2012 2010 2011
, :
) ... 17/2010
2010:
1 2012, ... . ...17/2010 (. 777/.
/04.06.2010) ,

50 . , 01.04.2012.
)
:
, ... -


(. 2079/. /20.09.2011) 14
( 50 . ),
. .
.
, 2012 61 (eauction),
25
. , 01.04.2012.
,
,
,
() () .

...

... 2

- ...,
... 2.
, 14.02.2012
...

... 2 14 ,

, 14.11.2011-18.11.2011,
.

. . 889/03.02.2012, :

:
... 2

30

-
. , ,
...

.

, ,

... (..)


2
, 10.02.2012
.. 8868/24.10.2011
: .. .. (

)
:
(..)

. 3846/2010, .
3580/2007 .., . 10
...
(observe-net)

, -

, ,

,
.
,
observe-net ,
... .
.
: 213 2010569 213 2010402.
.

.....
, 20.02.2012
. .: 378
...
:

,
. . 8868/24.10.2011
(2 10.02.2012), :

31

-
.
..... .
....
.
...
,


,
.

, ( ..., .., .),


.
,


.



10 .
,
.. .....

MSc


MSc

... 3/2011

, 17 2012
. .: 1304
:
/ ... 3/2011
/,
. 2/16.02.2012
. ... 3/2011,

, :
. :
1. DOXORUBICIN 50MG (11.545),
245.085,00
2. 
PROPOFOL 1% 20ML
(232.075), 624.469,00
3. PROPOFOL 1% 50ML (15.844),
118.040,00

32

4. PROPOFOL 1% 100ML
(27.288), 412.034,00
5. PROPOFOL 2% 50ML (78.573),
1.182.636,00
6. TEMOZOLOMIDE CAP. 5MG (4.659),
15.795,00
7. TEMOZOLOMIDE CAP. 20MG (12.880),
172.299,00
8. TEMOZOLOMIDE CAP. 100MG (22.895), 1.498.644,00
9. TEMOZOLOMIDE CAP. 140MG (5.660),
517.880,00
10.TEMOZOLOMIDE CAP. 180MG (1.625),
191.049,00
11. 
TEMOZOLOMIDE CAP. 250MG (6.295), 1.052.804,00
12. VANCOMYCIN 1000MG
(39.116), 450.197,00
13. METRONIDAZOLE CAP. 500MG (200.820), 16.300,00

-
14. CEFOXITIN 1G (721.150),
2.367.813,00
15. CEFOXITIN 2G (110.616),
585.287,00
16. PANTOPRAZOLE 40MG
(555.706), 2.470.813,00
17. MIDAZOLAM 15MG/3ML
(220.210), 216.313,00
18. AZITHROMYCIN TAB. 500MG (3.918),
5.055,00
19. CLINDAMYCIN 600MG (173.788), 346.959,00
20. HYDROCORTISONE 250MG (199.937), 282.562,00
21. HYDROCORTISONE 500MG (71.185), 127.072,00
. :
1. DOXORUBICIN 20MG , (19.005)
5.845.633,00
2. TEMOZOLOMIDE 2,5MG/ML
( ), (585) 138.279,00
.

,
25 :
1. DOXORUBICIN 10MG , (14.403)
68.509,00
2. AZITHROMYCIN TAB. 250MG, (55.722)
76.627,00

3. FLUCONAZOLE 100MG/50ML , (172.428) 807.675,00.


PFIZER HELLAS .. DOXORUBICIN 10MG,
IRINOTECAN 20MG/ML-5ML, IRINOTECAN 20MG/ML-2ML,
AZITHROMYCIN TAB. 250MG, CLINDAMYCIN 600MG
FLUCONAZOLE 100MG/50ML. 25
, . ,
.
DEMO .... VANCOMYCIN
1000MG, CEFTAZIDIME 2G, MIDAZOLAM 15MG/3ML
FLUCONAZOLE 100MG/50ML. 25
,
. ,

.
.... FLUCONAZOLE
100MG/50ML. 25 ,
. ,
.
, :


Business Exchanges


13/02/2012

15/02/2012

16/02/2012

12:00

21/02/2012

08:30
SULBACTAM +
AMPICILLIN (1+2)GR / : 3.654.338,54.


SULBACTAM + AMPICILLIN (0,5+1)GR
/ : 498.337,60.

33

21/02/2012



IRINOTECAN 20MG/ML-5ML / : 2.819.934,00.


IRINOTECAN 20MG/ML-2ML / : 346.368,00.


IRINOTECAN 20MG/ML-15ML / : 504.153,00.

08:30 RISPERIDONE TAB. 1MG / : 30.134,95.



RISPERIDONE TAB. 2MG / : 160.822,99.


22/02/2012 RISPERIDONE TAB. 3MG / :
333.362,52.


RISPERIDONE TAB. 4MG / :
616.668,86.


RISPERIDONE TAB. 6MG / :
41.351,52.

23/02/2012

34

08:30
GEMCITABINE 200MG / : 472.356,00.


GEMCITABINE 1000MG / : 1.994.520,00.

VANCOMYCIN 500MG / : 2.799.849,92.

23/02/2012


METRONIDAZOLE 500MG / : 1.314.024,40.

IMIPENEM + CILASTATIN
(500+500)MG / : 2.785.112,47.

.
,

...

01.03.2012, (...)
(....),
(e-uctions),
(5) 3.595.637,00, -

2010
....


:

CEFTAZIDIME 2G

9,09

1,98

1.053.573,00

EPIRUBICIN 10MG

8,51

5,58

MIDAZOLAM 50MG/10ML

2,99

2,13

METHYLPREDNISOLONE 125MG

1,71

1,27

METHYLPREDNISOLONE 40MG

1,20

0,88

230.048,46

-78,16%

-823.524,54

111.435,00

73.000,00

-34,49%

-38.435,00

1.382.848,00

984.155,85

-28,83%

-398.692,15

570.397,00

424.657,52

-25,55%

-145.739,48

477.384,00

348.948,16

-26,90%

-128.435,84

-42,69%

1.534.827,01

(e-auctions)


1.534.827,01 .

35

-

...






, ...
:

,
( /
). , , . .

3.000 ( 2011)
7.300 .
18%
, ,
50% .
40%

.
,
,
, 10 .

..
()
, (bioequivalence
study) (biowaiver justification)
.
(...),
,
,

36

...

(-
.. ..., ).
,
..
,
... :
.
:

,
. ,
.
 , , .

(OMCL) (Market Surveillance Studies,
MSS),
, (Centrally Authorized
Products, CAP) (MRP)
(DCP) .

... 1.000 , 900
() 4%.

.

-

... .

(EUGMP Certificate) ..
.

.
(,
, ).

. ,


...

 ,

(.. , ... .)
..,
.., ...,
EU GMP certificate.
,
,
,
(GMP certificate: ).
 ,
(EUAPIs GMP), ..
.
... 56
150
. ..., ,
/ (..., ,
.) .


..., ,

. 2
2012,
.
..., 2011, 81 ,
9 (
) 72 .
, 28 53 .

... , .
...


.


.

...


, 21.2.2012
. .: 13721

:


,
2 2012,

...

.
,
.

.
.
...

37

-
....
, 13.01.2012

11.02.2012, ..... ....
:

1. 
.
2.  - ().
3.  ( ,
2011 2012).
,

....

...
, 27.12.2011
. .: 369
: . ....
: - ...
. 4024/2011 ( 226/2011),
...,
,
, 28
, , ... . 1397/83, .
2071/92 . 2519/97.
. 4024/2011
:
1397/83 ( 143/17.10.1983), 10, 2:
.
2071/92 ( 123/15.07.1992): 89 90:
, ..., , .
8 89 90
40 44 . 2519/97.
75: .

38

2519/97 ( 165/21.08.1997), 40:


...,

, ...
, .
44

,
.
2716/99 24, . 8 9:
...
2194/94 ( 34/16.03.1994), 5, . 6:
.
2889/01 ( 37/02.03.2001): 2, . 6:
.
.
13, . 3: ... .
3204/03 ( 296/ 23.12.2004): 9: -

-
.
2, . 5 . 16:
. 21:
oo .
3209/04 ( 304/24.12.2004), 20: .
. 4/42289 , .
604, 8 2008, 7590-7593:

.
....

.. , ,
, ...
...
.
,
.. .....

MSc


MSc


...
, 13.01.2012
. .: 371

.
,

:
.
:
...

.. .....

MSc


MSc

,


...
:
1)

, ,
, & ..., . 2519/97
, ,
.
2)

400
.

39

-

, 13.01.2012
. .: 372
: . / .
:
,
,
.... , .
. . 2381/
26.10.2011

.
.

,
.

.
,
.. .....

MSc

MSc



, 02.02.2012
. .: 377
: .
:


.


.
:
1. : .
2. 
... .. . (
,
), ..... - .

40

3.  : .
4.  .
5.
 . 3816/11 ..
(6,5%)
+3%.
: ) ,
) ,
, ....,
.

.
.
.
,

.. .....

MSc

MSc

.....

.....,
,
.
16.500.. 82.. ,
:
1.
2. 108
3. .
, , 2 ,
! .
. , ;
, , ...
,
.
.. .

, 02.02.2012
. .: 376
: .. , .
.:
: . / 5, 11521

:
,
... , . , ,
.. 108/1993.
,
,
.
.
,
.....

42

, MSc

, MSc

,
, .
.
)  ,
.
)  ,
, . , ,
15 ( 2012)
. ,
. ;
; , ,
.

..


.....
:
21
2 . 3204/2003 8 7 . 2889/2001.
:
1.  , .
2.  , , ,
, .
3. 
, .
. ,
.
4.  . 2 87 . 3528/2007 , , , .
.
5.  3 (
)
,
( ).

43

, ,
,
,
.
:
 2 . 21 . 3204/2003 ( 296/23.12.2003) .
 7 . 2889/2001 (37/02.03.2001) , , .
 87 . 3528/2007 ( 26/02.02.2007) .
,
.....


MSc


MSc


:
2011, 77.000 2011
,
2011 ,
77.000 .
2012 .
.
,
...

44

.....

15 2011
15 , ,
..... ,
.
,
, .
. .....
.

: :

( )

( , ..)

 - (
/ )
( ;;;)
 ( , -
)


(guide lines)
 -
(-, .)
-

-

45

.....
.....
30
, .
- .
.
, .
, .
.
,
.

46

.....

47




! . . ..
.... . .
...

.

,
.

21
. .
& ()
13 2011 19.00,
..
.
,
-
(), .
. .
. .
,
. . :
:
,

.
1975. 1981-82
. 1984
: -.
(2007)

48

2010
(New Orleans, LU, USA).

,

.
()
, . .
.
, 1990.

.
, ,
.
:


. .
.: 2810 391509, Fax: 2810 391513
E-mail: kalliroi@admin.forth.gr


Janssen-Cilag Caelyx

JANSSEN-CILAG ...
. 56
151 21,
210 61 40 061 .
210 61 40 072 fax
www.janssen.com.gr
12 2011
:


Caelyx (
) 20mg
,
, 22 2011, Caelyx, .

2011 .
Caelyx .
,

BVL. , Caelyx ,
, /
.
,
, Janssen-Cilag
International N.V. Belgium, :

 Caelyx


 Caelyx,
.

:

 ( )
Caelyx.

 (.
) .

Caelyx,
,
.
. ,
,
Caelyx .

,

Caelyx (patient allocation programme)
.
Caelyx
2011.



.



Caelyx. ,
.


,
.

49


.
, ,

.
.


:
,
,
.
...: www.eof.gr
( .: 213 2040380) .

Janssen-Cilag ....
:

 : 210 8090000, 210 8090640, 210 8090725

fax: 210 6129190

e-mail: farmaco@its.jnj.com


Janssen-Cilag .... :
210 8090720.
,


; ... .
, ...

50

51

52

53

-
1 :

1 : ,

, ,
27-30 2012, ,
.
..... .
.: 210 3668853 e-mail: pharmacongress@afea.gr

.....:
- : 9:30.. - 14:00..

54